Chromosomal architecture and placental expression of the human growth hormone gene family are targeted by pre-pregnancy maternal obesity

American Journal of Physiology. Endocrinology and Metabolism
Yan JinP A Cattini

Abstract

The human (h) placental lactogenic hormone chorionic somatomammotropin (CS) is highly produced during pregnancy and acts as a metabolic adaptor in response to maternal insulin resistance. Maternal obesity can exacerbate this "resistance", and a >75% decrease in CS RNA levels was observed in term placentas from obese vs. lean women. The genes coding for hCS ( hCS-A and hCS-B) and placental growth hormone ( hGH-V) as well as the hCS-L pseudogene and pituitary growth hormone (GH) gene ( hGH-N) are located at a single locus on chromosome 17. Three remote hypersensitive sites (HS III-V) located >28 kb upstream of hGH-N as well as local hCS gene promoter and enhancer regions are implicated in hCS gene expression. A placenta-specific chromosomal architecture, including interaction between HS III-V and hCS but not hGH gene promoters, was detected in placentas from lean women (BMI <25 kg/m2) by using the chromosome conformation capture assay. This architecture was disrupted by pre-pregnancy maternal obesity (BMI >35 kg/m2), resulting in a predominant interaction between HS III and the hGH-N promoter, which was also observed in nonplacental tissues. This was accompanied by a decrease in hCS levels, which was consistent with reduced RNA p...Continue Reading

References

Jun 1, 1988·The Journal of Clinical Endocrinology and Metabolism·F FrankenneG Hennen
Jan 1, 1983·The Journal of Clinical Endocrinology and Metabolism·G T PeakeJ Standefer
Dec 1, 1993·The Quarterly Review of Biology·D Haig
Dec 1, 1995·Molecular and Cellular Biology·B K JonesN E Cooke
Aug 5, 1999·Journal of the National Cancer Institute·R X Luo, D C Dean
Feb 16, 2002·Science·Job DekkerNancy Kleckner
Mar 21, 2002·American Journal of Obstetrics and Gynecology·Linda A BarbourJacob E Friedman
Jun 28, 2002·Diabetes·John P KirwanPatrick M Catalano
Dec 24, 2003·Virchows Archiv : an International Journal of Pathology·Ana-Maria BambergerThomas Löning
Jul 20, 2007·Molecular and Cellular Biology·Atsushi P KimuraStephen A Liebhaber
Sep 6, 2007·The Journal of Biological Chemistry·Jean-Baptiste JomainVincent Goffin
Dec 1, 2007·Molecular Biology and Evolution·Tamaki YuriMichael J Braun
Jul 21, 2009·American Journal of Reproductive Immunology : AJRI·Matthew A Maccani, Carmen J Marsit
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·David Haig
May 7, 2010·The Journal of Clinical Endocrinology and Metabolism·Michael Freemark
Aug 9, 2011·Brain, Behavior, and Immunity·C M Larsen, D R Grattan
Oct 12, 2011·Current Opinion in Endocrinology, Diabetes, and Obesity·Dorothee Newbern, Michael Freemark
Feb 25, 2014·Nucleic Acids Research·Yu-Cheng TsaiStephen A Liebhaber
May 3, 2014·Obstetrics and Gynecology·Emma MolyneauxLouise M Howard
Aug 12, 2014·Cytokine & Growth Factor Reviews·Jie WangPeter A Cattini
Oct 9, 2014·The Journal of Clinical Investigation·Hana VakiliPeter A Cattini
Dec 17, 2014·Frontiers in Neuroendocrinology·Robert S Bridges

❮ Previous
Next ❯

Methods Mentioned

BETA
amplicon sequencing
PCR
electrophoresis
enzyme-linked immunosorbent assay
immunoprecipitation
ChIP-PCR
amplicon sequencings
ELISA
ChIP

Software Mentioned

Activemotif
Trim Galore
Miseq

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.